The Web's First Cancer Resource OncoLink en espanolOncoLink en espanõl

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Quick Search: advanced search
emailPrint | emailEmail | OncoLink - Share Share | Thursday, September 2, 2010
Cancer Resources

Cancer Resources > Cancer News > 2005 > December

Reuters

Insulin and insulin resistance linked to exocrine pancreatic cancer

Last Updated: 2005-12-13 17:14:37 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Exposure to higher insulin levels and insulin resistance appears to mediate the association between type 2 diabetes and pancreatic cancer, new study findings suggest.

A relationship between diabetes and pancreatic cancer has long been recognized, the authors of the study note. The question, however, is whether diabetes is involved in the etiology of pancreatic carcinogenesis, or is simply the result of subclinical malignancy.

To find answers, Dr. Rachael Z. Stolzenberg-Solomon and colleagues conducted a prospective case-cohort study that included data from the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. The current analysis, initiated in subjects without clinical evidence of cancer during the first 5 years of follow-up, is published in the Journal of the American Medical Association for December 14.

Excluding patients with islet cell carcinomas, there were 169 patients with exocrine pancreatic cancer, with whom the authors compared a random sample of 400 subjects who were alive without a cancer diagnosis at year 5. All subjects were smokers who were ages 50 to 69 years between 1985 and 1988, followed for a median of 13.8 years.

"After adjustment for age, years of smoking, and BMI, higher concentrations of glucose, insulin, and insulin resistance tended to show positive dose-response associations with pancreatic cancer," the authors report.

The presence of diabetes and the highest insulin quartile raised the risk 2-fold, and risks were greater among cases that occurred with longer follow-up time, findings that they say "support the veracity of our results."

The long, prospective follow-up means that elevated insulin and insulin resistance were probably not the consequence of pancreatic cancer, Dr. Stolzenberg-Solomon and her colleagues add.

"Lifestyle changes to decrease glucose and insulin concentrations through weight reduction, increasing physical activity, and diet, such as decreasing saturated fat intake, ...could possibly impact pancreatic cancer development," they conclude.

JAMA 2005;294:2872-2878.

«Previous | 1 | Next »

Copyright © 2010 Reuters Limited. All rights reserved.
Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.